Cam Gallagher

President at Zentalis Pharmaceuticals Inc.

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
8 years
Director since
2023

8 years of board service in total across 2 boards, counting each seat separately. Longest: Zentalis Pharmaceuticals Inc., 3 years.

Zentalis Pharmaceuticals Inc. Director · President, Interim CFO
3 years · Since 2023
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 8, 2026 Opus Genetics Inc. Option exercise +784,314 $1.15 $901,961
Apr 20, 2026 Opus Genetics Inc. Grant or award +24,367 — —
Jan 6, 2026 Opus Genetics Inc. Grant or award +67,000 — —
Dec 31, 2025 Opus Genetics Inc. Grant or award +33,000 — —
Dec 29, 2025 Opus Genetics Inc. Open-market purchase +81,000 $1.98 $160,380
Dec 29, 2025 Opus Genetics Inc. Open-market purchase +83,000 $1.97 $163,510
Aug 25, 2025 Opus Genetics Inc. Grant or award +869,565 $1.15 $1,000,000
Apr 30, 2025 Opus Genetics Inc. Grant or award +79,504 — —
Mar 24, 2025 Opus Genetics Inc. Grant or award +784,314 — —
Jun 11, 2024 Opus Genetics Inc. Grant or award +41,143 — —
May 31, 2024 Zentalis Pharmaceuticals Inc. Open-market sale −9,597 $11.98 $114,972
Feb 12, 2024 Zentalis Pharmaceuticals Inc. Open-market sale −1,173 $11.44 $13,419
Feb 2, 2024 Zentalis Pharmaceuticals Inc. Open-market sale −11,552 $11.54 $133,310
Feb 1, 2024 Zentalis Pharmaceuticals Inc. Grant or award +192,500 — —
Jun 6, 2023 Opus Genetics Inc. Grant or award +10,976 — —

Questions about Cam Gallagher

What boards is Cam Gallagher on?

Cam Gallagher sits on the boards of Opus Genetics Inc. and Zentalis Pharmaceuticals Inc.

How long has Cam Gallagher served on boards?

Our records show at least 8 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.